US · Healthcare

Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY)

Medical Distribution

Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) is listed on US in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SHPMY

P/E ratio

18.00

Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) — FAQ

What is SHPMY's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) is 18.00 (data as of 2026-03-25).

Does Shanghai Pharmaceuticals Holding Co Ltd ADR pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY). Check the MyAverix Finance app for the latest dividend data.

What sector is Shanghai Pharmaceuticals Holding Co Ltd ADR in?

Shanghai Pharmaceuticals Holding Co Ltd ADR (SHPMY) is classified in the Healthcare sector (Medical Distribution industry).

What exchange is SHPMY listed on?

SHPMY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)